Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
LD liked this manufacturer product
https://www.launchdiagnostics.com/product/bosphore-streptococcus-pneumoniae-detection-kit-v1/
-------------------
"Anatolia GeneworksAnatolia Geneworks
4,721 followers4,721 followers
9h • 9h •
Follow
Early Strep A treatment is important!
Streptococcus pyogenes, the bacterium that causes Strep A, creates flu-like symptoms, nausea, vomiting and, most importantly, a sore throat. The disease can be fatal in children under 15 and people over 65. Rapid treatment is possible with early diagnosis. Bosphore Streptococcus pyogenes (Group A) Detection Kit provides fast and reliable results and helps initiate rapid intervention."
November 2023 Nice little article on affimers if not seen before - promising asset waiting in the wings
https://benchmarkantibodies.com/index.php/2023/11/02/affimers-the-rising-stars-in-molecular-recognition/
Have devastating side effects - need for novel solutions - Huge global market for Avacta US $ 331 billion by end 2032 .
Very good reason for shareholders to hang around , no reason Avacta will not eventually , get a slice of that revenue cake .
------------------
The pre|CISION™ tumour microenvironment activated chemotherapy platform releases active drug only within the tumour microenvironment – limiting systemic exposure and enhancing the safety and therapeutic potential of treatments for oncology indications. The pre|CISION™ tumour microenvironment activated chemotherapy platform releases active drug only within the tumour microenvironment – limiting systemic exposure and enhancing the safety and therapeutic potential of treatments for oncology indications. The pre|CISION™ tumour microenvironment activated chemotherapy platform releases active drug only within the tumour microenvironment – limiting systemic exposure and enhancing the safety and therapeutic potential of treatments for oncology indications.
---------------------------------------
https://www.persistencemarketresearch.com/market-research/chemotherapy-drugs-market.asp#:~:text=Worldwide%20revenue%20from%20the%20chemotherapy%20drugs%20market%20is,the%20last%209%20years%20from%202012%20to%202021.
Great to see ONDO making progress with Water companies ,
https://twitter.com/foster_ideas/status/1762010879648833824
Craig Foster
@foster_ideas
·
1h
8% of UK toilets leak - wasting 400 ml/day - enough water to meet the needs of Birmingham, Manchester, Sheffield and Leeds.
LeakBot can find and fix them. Significant step today with South West Water deploying 6,000 LeakBots in a rapid intervention re to reduce leaks #ONDO
Quote
Ondo InsurTech Plc
@OndoPlc
·
1h
*RNS* @SouthWestWater deploy LeakBot to prevent water leaks. South West Water, part of Pennon Group PLC, provides water and wastewater services to 1.8 million customers across the South West. #ONDO #MadeInBritain #GreenEconomy
https://londonstockexchange.com/news-article/ONDO/new-agreement-with-south-west-water/16347683
Good Morning added a few more , every confidence Avacta will deliver , expect positive news flow throughout 2024 so the journey starts again , first step see my current deficit -33.75% decrease then onwards /upwards we go ..
Have a fun day in the AVCT madhouse .
Avacta have a licence with PB/Lilly : Might be of interest .
"Leila SafaviLeila Safavi
• 3rd+• 3rd+
Innovative Entrepreneur and CEO | Nuclear Technology Expert | Revolutionizing Healthcare with Radioisotopes | Forbes NEXT 1000 Entrepreneur | Oncidium Foundation AmbassadorInnovative Entrepreneur and CEO | Nuclear Technology Expert | Revolutionizing Healthcare with Radioisotopes | Forbes NEXT 1000 Entrepreneur | Oncidium Foundation Ambassador
1d • 1d •
Follow
☢️ Shining a Light on Progress: Radioisotope Clinical Trials Update! ☢️
The field of radiopharmaceuticals is booming, with innovative therapies utilizing radioisotopes like Lu-177, Ac-225, and Pb-212 holding immense potential for treating various diseases. But where do these promising treatments stand in terms of clinical trials?
I'm sharing this image to visualize the current landscape of radioisotope clinical trials. Each isotope offers unique properties and therapeutic advantages, and the image provides a snapshot of their progress.
It's crucial to remember that this is just a glimpse into the dynamic world of radioisotope clinical trials. Here are some additional points to consider:
💫Rapidly evolving landscape: New radioisotopes and targeted agents emerge constantly, pushing the boundaries of clinical research.
💫Collaborative efforts: Partnerships between researchers, clinicians, and pharmaceutical companies are crucial for accelerating development and overcoming challenges.
💫 Focus on unmet needs: Radiopharmaceuticals offer hope for patients with limited treatment options, driving continued investment and research efforts.
🚀 The future is bright: The progress highlighted, along with the ongoing research and development, paints a promising picture for the future of radioisotope therapy. These targeted treatments have the potential to revolutionize healthcare, offering personalized and effective solutions for a wider range of diseases.
Join the conversation!
💡What excites you most about the potential of radioisotope therapies?
💡Are there specific diseases you hope these treatments will address?
💡What role can we play in supporting the advancement of this field?
Share your thoughts and questions in the comments below! Let's continue to shine a light on the progress and potential of radioisotope clinical trials.
Activate to view larger image,
Image preview
https://www.linkedin.com/posts/leilasafavi_shining-a-light-on-progress-radioisotope-activity-7165832523615334402-hfhT/
Why is Wyn not buying --- RSI signals flashing SP between 14 Day RSI at 30% 88.794 - 14 Day RSI at 20% 77.584 ?
Surely loading up ?
https://www.barchart.com/stocks/quotes/AVCT.LN/cheat-sheet
Or of course you could just hold and/or buy a few more , easy to view the past & repetitively ask why why why ?Will not change anything .
Personally i have high expectations that the future is indeed very bright for Avacta shareholders .
Good that Avacta have JV partners making progress using affimer techonology .:
"Company Introduction
Apicell Therapeutics Co., Ltd. is a company specializing in the development of next-generation cell and gene therapy products jointly funded by Daewoong Pharmaceutical and Avacta Life Science in the UK.
We are developing next-generation cell and gene therapy products (AFX platform technology) optimized for immune modulation by combining the Affimer platform technology to strengthen immune modulation based on the next-generation mesenchymal stem cell platform technology that overcomes the limitations of adult tissue-derived mesenchymal stem cells."
Thanks alextak - link from website
http://affyxell.com/bbs/?so_table=recruit&mode=VIEW&num=4&category=&findType=&findWord=&sort1=&sort2=&page=1
Guess LD might remain Avacta asset at least for the time being :
https://www.brayfoxsmith.com/property/lakeview-west-dartford/
https://www.launchdiagnostics.com/news/launch-diagnostics-moves-to-a-new-office/
"21 FEBRUARY 2024
Launch Diagnostics will be moving from its current office at Ash House, Ash Road, New Ash Green, Longfield, Kent to new premises.
From Monday 26th February 2024 our new office address will be:
Launch Diagnostics Limited, Lakeview West, Crossways Business Park, Galleon Boulevard, Dartford, Kent DA2 6QE
Please note, our telephone numbers will remain the same.
In addition, the Warehouse and Technical Department will still be located at its current location, so there will be no change to our delivery/despatch address
Unit 11, West Yoke Farm, Michaels Lane, Ash, New Ash Green, Sevenoaks TN15 7EP"
$ billion market cap company Selective Insurance Group
https://www.selective.com/
Good Morning “You can fool some of the people all of the time, and all of the people some of the time, but you can not fool all of the people all of the time.” .Our resident naysayer needs to get his act together seems rather confused if aspiring to be a competent FUDster .
How can someone who claims to have a AVCT core holding who is fixated with the SP also says never gets emotionally involved , has habit of repeating for "the millionth time " being able to keep the company & SP separate . Yet spend so much time spreading negative sentiment about the company asking why?why?why? Seems a very confused individual with a not so secret very boring agenda .
On a happy note added a few more shares today make no apologies for supporting my investment . Avacta LSE message board " madhouse " aptly named .
Linkedin likes - products from Meridian & Liofilchem
"Launch Diagnostics Limited likes this
Meridian Bioscience Inc.
Meridian Bioscience Inc.Meridian Bioscience Inc.
19,538 followers19,538 followers
19h • 19h •
Prenatal screening for Group B Strep (GBS) is important, but using the right test is also important! Studies have shown that approx. 80% of the cases of GBS Early Onset Disease (EOD) are born to mothers with a negative culture result.
February is International Prenatal Infection Prevention Month. Let's all do our part to raise awareness of prenatal infections, more importantly, let's prevent them.
To learn more about Meridian Bioscience's pediatric solutions visit, https://hubs.la/Q02lfMn70
https://www.launchdiagnostics.com/products/
-------------------------------
Launch Diagnostics LimitedLaunch Diagnostics Limited
1,471 followers1,471 followers
20h • 20h •
Liofilchem produces a vast range of high quality antimicrobial susceptibility testing (AST) products for all your testing needs. They also provide excellent support, training and information to ensure your lab's AST runs as smoothly as possible! Launch Diagnostics is the exclusive distributor of Liofilchem in the UK.
For more information head to: https://lnkd.in/e7nK4dMR
https://www.liofilchem.com/solutions/clinical/arm
https://www.launchdiagnostics.com/product/mic-test-strip-amikacin/
https://www.linkedin.com/feed/update/urn:li:activity:7163833563501522944/
Or contact:
enquiries@launchdiagnostics.com
Courtesy of twitter : Bachochin’s FAP inhibitor, gets fast track approval - science validated -why not AVA6000 next .
https://ir.bioxceltherapeutics.com/news-releases/news-release-details/bioxcel-therapeutics-receives-fda-fast-track-designation-bxcl701#:~:text=NEW%20HAVEN%2C%20Conn.%2C%20Feb.%2012%2C%202024%20%28GLOBE%20NEWSWIRE%29,on%20chemotherapy%20and%20no%20evidence%20of%20microsatellite%20instability.
BioXcel Therapeutics Receives FDA Fast Track Designation for BXCL701 for Treatment of Small Cell Neuroendocrine Prostate Cancer (SCNC)
------------------------------------
"Talabost BXCL701 (talabostat previously PT100) "
Talabost also known as Bachochin’s FAP inhibitor, is a small molecule that inhibits the dipeptidyl peptidase activity shared by DPPIV (dipeptidyl peptidase IV) and FAP (fibroblast activation protein-α). Preliminary findings indicate that oral talabostat treatment slows tumor growth in mouse models of fibrosarcoma, lymphoma, melanoma, rhabdomyosarcoma, and bladder cancer cell lines1. FAP plays a crucial role in promoting tumor growth, invasion, metastasis, and immunosuppression. It is specifically expressed by cancer-associated fibroblasts (CAFs) in the tumor stroma. For instance, in females with a high incidence of breast cancer, CAFs account for 50–70% of the cells in the tumor’s microenvironment1.
The development of FAP inhibitors like talabostat holds promise for the diagnosis and treatment of various cancers. Researchers are also exploring the use of nanomaterials that target FAP in both basic and clinical research1. The field of FAP inhibition continues to evolve, and these advancements may contribute significantly to cancer management."
https://twitter.com/RAH00084/status/1759838072840114377
Good to see Daewoong making good use of AI : Perhaps might of benefit to Avacta JV --- AffyXell Therapeutics Co.,Ltd. development of next-generation cell and gene therapies
" After 2 years of preparation, we completed the construction of our own AI drug discovery system 'DAISY'... Began to be used to discover candidate substances– Collected 800 million compounds known to the world and built a database, named 'DAVID'
Maybe help speed up the clinical process : " By discovering and designing candidate substances using AI, the 'time' of new drug development is being shortened." -"In the future, the company plans to expand the use of AI throughout the drug development cycle, including preclinical, clinical, and marketing processes."
Daewoong Pharmaceutical, '800 million types of compounds' pre-treated and turned into DB... Combining a unique AI drug system to 'speed up' obesity and anti-cancer research
https://www.koreabiomed.com/news/articleView.html?idxno=23381
https://newsroom.daewoong.co.kr/archives/22542